Analyzing rich data using different methods provided by NONMEM: pharmacokinetics of telmisartan following intravenous infusion to healthy volunteers.
Wallenstein
G C
GC
Dep. of Medical Data Services, Boehringer Ingelheim Pharma KG, Ingelheim, Germany. wallenst@ing.boehringer-ingelheim.com
Stangier
J
J
Ludden
T M
TM
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001565:Benzoates / Q000008:administration & dosage / Q000493:pharmacokinetics*; D018592:Cross-Over Studies; D006801:Humans; D007262:Infusions, Intravenous; D007700:Kinetics; D008297:Male; D017711:Nonlinear Dynamics; D012984:Software; D000077333:Telmisartan
D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D000077333:Telmisartan